Physician profile
Cindy A Hudson
NPI 1073640512
$1,246.16
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $777 · 2020: $77.94 · 2021: $136 · 2022: $256.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $655.18 | 2019-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $153.50 | 2019 | |
| Genzyme Corporation | $121.35 | 2019 | |
| Novartis Pharmaceuticals Corporation | $118.77 | 2019 | |
| Coopervision INC. | $89.71 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $47.92 | 2022 | |
| Johnson & Johnson Vision Care, INC. | $38.66 | 2019 | |
| Shire North American Group INC | $21.07 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cindy Hudson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.